Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value: $1.265B (100.0% shares, 0.0% debt)

Holdings (32)

BMRN BIOMARIN PHARMACEUTICAL INC 13.2%
Value $168M Shares 1,976,265 Share Price $84.77 * Est. Cost/Share $83.16 Unrealized @ Report Date +7.1%
UTHR UNITED THERAPEUTICS CORP 10.5%
Value $133M Shares 633,534 Share Price $209.38 * Est. Cost/Share $89.23 Unrealized @ Report Date +150.5%
INSM INSMED INC 9.9%
Value $126M Shares 5,840,398 Share Price $21.54 * Est. Cost/Share $17.79 Unrealized @ Report Date +34.8%
— ABIOMED INC 9.5%
Value $121M Shares 490,754 Share Price $245.66 Est. Cost/Share $81.43 Unrealized @ Report Date —
— REVANCE THERAPEUTICS INC 9.4%
Value $119M Shares 4,405,039 Share Price $27.00 Est. Cost/Share $21.99 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 8.1%
Value $103M Shares 9,847,774 Share Price $10.44 * Est. Cost/Share $9.52 Unrealized @ Report Date +17.1%
PRTA PROTHENA CORP PLC 7.9%
Value $100M Shares 1,649,777 Share Price $60.63 * Est. Cost/Share $21.46 Unrealized @ Report Date +47.3%
BIIB BIOGEN INC 7.6%
Value $96.38M Shares 360,981 Share Price $267.00 * Est. Cost/Share $264.06 Unrealized @ Report Date -19.6%
STAA STAAR SURGICAL CO 6.1%
Value $77.39M Shares 1,096,882 Share Price $70.55 * Est. Cost/Share $14.28 Unrealized @ Report Date +499.5%
— SAGE THERAPEUTICS INC 2.6%
Value $33.34M Shares 851,409 Share Price $39.16 Est. Cost/Share $46.62 Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 2.4%
Value $30.69M Shares 5,621,533 Share Price $5.46 Est. Cost/Share $16.36 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 2.2%
Value $27.45M Shares 1,678,196 Share Price $16.36 Est. Cost/Share $33.89 Unrealized @ Report Date -52.2%
VNDA VANDA PHARMACEUTICALS INC 1.7%
Value $21.4M Shares 2,166,156 Share Price $9.88 * Est. Cost/Share $11.21 Unrealized @ Report Date -5.8%
GOSS GOSSAMER BIO INC 1.7%
Value $20.97M Shares 1,750,651 Share Price $11.98 * Est. Cost/Share $11.85 Unrealized @ Report Date +4.8%
SNDX SYNDAX PHARMACEUTICALS INC 1.2%
Value $14.72M Shares 612,600 Share Price $24.03 * Est. Cost/Share $16.84 Unrealized @ Report Date +33.3%
ALKS ALKERMES PLC 1.1%
Value $13.47M Shares 603,400 Share Price $22.33 * Est. Cost/Share $22.36 Unrealized @ Report Date +16.3%
ANAB ANAPTYSBIO INC 0.9%
Value $10.99M Shares 431,024 Share Price $25.51 * Est. Cost/Share $19.06 Unrealized @ Report Date +23.0%
ALGN ALIGN TECHNOLOGY INC 0.7%
Value $9.176M Shares 44,305 Share Price $207.11 * Est. Cost/Share $114.31 Unrealized @ Report Date +125.2%
EHTH EHEALTH INC 0.6%
Value $7.734M Shares 1,977,993 Share Price $3.91 * Est. Cost/Share $50.83 Unrealized @ Report Date -86.3%
— GRITSTONE ONCOLOGY INC 0.5%
Value $5.989M Shares 2,330,504 Share Price $2.57 Est. Cost/Share $9.42 Unrealized @ Report Date —
— KEZAR LIFE SCIENCES INC 0.4%
Value $5.65M Shares 656,200 Share Price $8.61 Est. Cost/Share $5.16 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.4%
Value $5.413M Shares 111,717 Share Price $48.45 Est. Cost/Share $6.71 Unrealized @ Report Date +616.9%
— CLOVIS ONCOLOGY INC 0.4%
Value $5.324M Shares 4,473,967 Share Price $1.19 Est. Cost/Share $42.71 Unrealized @ Report Date —
TVTX TRAVERE THERAPEUTICS INC 0.3%
Value $4.092M Shares 166,069 Share Price $24.64 * Est. Cost/Share $23.56 Unrealized @ Report Date +9.7%
— PROVENTION BIO INC 0.1%
Value $1.759M Shares 390,800 Share Price $4.50 Est. Cost/Share $4.50 Unrealized @ Report Date —
MIRM MIRUM PHARMACEUTICALS INC 0.1%
Value $1.359M Shares 64,700 Share Price $21.00 * Est. Cost/Share $15.56 Unrealized @ Report Date +54.8%
— ALIMERA SCIENCES INC 0.1%
Value $1.021M Shares 200,919 Share Price $5.08 Est. Cost/Share $6.30 Unrealized @ Report Date —
ALDX ALDEYRA THERAPEUTICS INC 0.1%
Value $859K Shares 160,800 Share Price $5.34 * Est. Cost/Share $7.10 Unrealized @ Report Date -15.5%
— MAGENTA THERAPEUTICS INC 0.0%
Value $610K Shares 432,300 Share Price $1.41 Est. Cost/Share $7.38 Unrealized @ Report Date —
TCMD TACTILE SYSTEMS TECHNOLOGY I 0.0%
Value $211K Shares 27,100 Share Price $7.79 * Est. Cost/Share $39.74 Unrealized @ Report Date -79.0%
— MARINUS PHARMACEUTICALS INC 0.0%
Value $208K Shares 31,330 Share Price $6.64 Est. Cost/Share $15.48 Unrealized @ Report Date —
URGN UROGEN PHARMA LTD 0.0%
Value $204K Shares 24,500 Share Price $8.33 Est. Cost/Share $27.01 Unrealized @ Report Date -69.4%